Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 2/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.46 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.43 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.43 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11294180 | 0.97 | ADRA1A (0.46) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL1335604 | 0.94 | ADRA1A (0.48) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL5354813 | 0.93 | GPR84 (0.52) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL10339228 | 0.91 | ADRA1A (0.41) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL9118868 | 0.91 | ADRA1A (0.41) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL30423955 | 0.91 | FOLH1 (0.46) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL10557994 | 0.91 | FOLH1 (0.46) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL1251084 | 0.91 | GPR84 (0.50) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL21274454 | 0.91 | ADRA1A (0.41) | ADRA1AHDAC1HDAC2TDP1CHRM1 | |
| SCHEMBL940383 | 0.90 | ADRA1A (0.44) | ADRA1AHDAC1HDAC2TDP1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320174-A1 | SPIN ON METAL-ORGANIC FORMULATIONS | MERCK PATENTS GMBH (DE) | 2025-10-16 | — | — | US | claimed |
| EP-4334252-A2 | SPIN ON METAL-ORGANIC FORMULATIONS | Merck Patent GmbH (DE) | 2024-03-13 | — | — | EP | claimed |
| WO-2022233919-A2 | SPIN ON METAL-ORGANIC FORMULATIONS | MERCK PATENT GMBH (DE) | 2022-11-10 | — | — | WO | claimed |
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-103936893-A | Catalyst component for olefin polymerization and catalyst | BEIJIG LIHE ZHIXIN TECHNOLOGY LTD | 2014-07-23 | — | — | CN | claimed |
| CN-103936892-A | Solid catalyst component for olefin polymerization and catalyst | BEIJIG LIHE ZHIXIN TECHNOLOGY LTD | 2014-07-23 | — | — | CN | claimed |
| CN-103923237-A | Catalyst component for olefin polymerization and application thereof | BEIJING LIHE ZHIXIN TECHNOLOGY CO LTD | 2014-07-16 | — | — | CN | claimed |
| CN-103922928-A | Ring substituted ether acid ester compound suitable for preparing olefin polymerization catalyst | BEIJING LIHE ZHIXIN TECHNOLOGY CO LTD | 2014-07-16 | — | — | CN | claimed |
| CN-103923238-A | Catalyst component for olefin polymerization and catalyst | BEIJING LIHE ZHIXIN TECHNOLOGY CO LTD | 2014-07-16 | — | — | CN | claimed |
| US-6538013-B2 | As a pour-on or spot-on on formulation for controlling parasites such as fleas in warm blooded animals; such as 2,2-dimethylbutyric acid, (1-((6-chloro-pyridin-3-ylmethyl)-ethyl-amino)-2-nitrovinyl)-methyl -carbamoyloxy)-methyl ester | NOVARTIS ANIMAL HEALTH US, INC. | 2003-03-25 | — | — | US | claimed |
| EP-0018342-B1 | NOVEL DERIVATIVES OF GLYCERIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANOFI S.A. (FR) | 1983-02-16 | — | — | EP | claimed |
| US-4025649-A | INHIBITORS OF A TRANSAMINASE ENZYME, ANTIANOXIC, ANTICONVULSANT | LABAZ (FR) | 1977-05-24 | — | — | US | claimed |
| CN-116659004-B | Air conditioner | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-26 | — | — | CN | disclosed |
| EP-4711434-A1 | REFRIGERANT CYCLE APPARATUS | Daikin Industries, Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4234293-B1 | REFRIGERATION CYCLE DEVICE FOR VEHICLE | DAIKIN IND LTD (JP) | 2025-12-24 | — | — | EP | disclosed |
| EP-4641061-A1 | OIL-WELL METAL PIPE | NIPPON STEEL CORPORATION (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-0911035-A2 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-04-28 | — | — | EP | disclosed |
| CN-1132752-A | Beta-lactam derivatives, process for their preparation and their use | HOFFMANN LA ROCHE (CH) | 1996-10-09 | — | — | CN | disclosed |
| US-4071623-A | ESTROGENICALLY ACTIVE STEROIDS | AKZONA INCORPORATED (US) | 1978-01-31 | — | — | US | disclosed |
| US-4025649-A | INHIBITORS OF A TRANSAMINASE ENZYME, ANTIANOXIC, ANTICONVULSANT | LABAZ (FR) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320174-A1 | SPIN ON METAL-ORGANIC FORMULATIONS | SLC39A11, SLC39A3, SLC39A7 | ADRA1A 4158/4885HDAC1 2225/4885HDAC2 2026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.